Web Analysis for Bmsi - bmsi.co.in
Learn more about Bristol-Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.
bmsi.co.in is 1 decade 5 years old. It is a domain having co.in extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently by users, bmsi.co.in is SAFE to browse.
PageSpeed Score
Siteadvisor Rating
Traffic Report
Daily Unique Visitors: | Not Applicable |
Daily Pageviews: | Not Applicable |
Estimated Valuation
Income Per Day: | $ 0.15 |
Estimated Worth: | $ 8.95 |
Search Engine Indexes
Google Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
Google Backlinks: | 48,700 |
Bing Backlinks: | Not Applicable |
Safety Information
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | No Risk Issues |
WOT Trustworthiness: | Not Applicable |
WOT Child Safety: | Not Applicable |
Website Ranks & Scores
Alexa Rank: | Not Applicable |
Domain Authority: | Not Applicable |
Web Server Information
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
H1 Headings: | Not Applicable | H2 Headings: | 2 |
H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
H5 Headings: | 5 | H6 Headings: | Not Applicable |
Total IFRAMEs: | Not Applicable | Total Images: | 3 |
Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Websites Hosted on Same IP (i.e. 198.155.184.133)
Bristol-Myers Squibb (BMS) - entreprise biopharmaceutique d’envergure
Découvrez Bristol-Myers Squibb et sa mission visant à découvrir, développer et fournir des médicaments innovants qui aident les patients à vaincre des maladies graves.
Bristol-Myers Squibb - 跨国生物制药公司
深入了解Bristol-Myers Squibb以及我们的使命——探索、研发创新性药物,并将它交给患有重大疾病的患者。
BMS HEALTHCARE:医療関係者向け情報サイト
「BMS HEALTHCARE」はブリストル・マイヤーズ スクイブ株式会社が提供する医療関係者向け情報サイトです。
ORENCIA® (abatacept) | Official Patient Site
ORENCIA® (abatacept) is a prescription medication for moderate to severe Adult Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Adult Psoriatic Arthritis. Please see Indication and Important Safety Information.
YERVOY®(ipilimumab) | Consumer | Gateway
YERVOY is a prescription medicine used in adults and children 12 years of age and older to treat melanoma. See Indication, Important Safety Information, and Boxed Warning.
HTTP Header Analysis
Content-Type: text/html;charset=utf-8
Content-Length: 42939
Connection: close
Date: Fri, 27 Dec 2019 20:08:26 GMT
Server: Apache
X-Content-Type-Options: nosniff
Last-Modified: Wed, 18 Dec 2019 17:41:13 GMT
ETag: "a7bb-599fdf367e040"
Accept-Ranges: bytes
X-Dispatcher: dispatcher1useast1
X-Dispatcher-Number: 1
X-Vhost: publish
X-Frame-Options: SAMEORIGIN
Cache-Control: max-age=900,s-maxage=1800
Vary: Host,Accept-Encoding,User-Agent
X-Cache: Miss from cloudfront
Via: 1.1 446313511980eb02f28ff5a9a4147c0a.cloudfront.net (CloudFront)
X-Amz-Cf-Pop: HIO50-C1
X-Amz-Cf-Id: wnpFNzlJI55qZw-l4Q29UX152Mgd9qiF8rpzi7RXRUsmG0R5A3Nd_Q==
Domain Information
Domain Nameserver Information
Host | IP Address | Country | |
---|---|---|---|
ns1.bms.com | 198.155.167.250 | United States of America | |
ns2.bms.com | 198.155.167.248 | United States of America | |
ns3.bms.com | 198.155.223.8 | Germany |
DNS Record Analysis
Host | Type | TTL | Extra |
---|---|---|---|
bmsi.co.in | A | 298 |
IP: 198.155.184.133 |
bmsi.co.in | NS | 300 |
Target: ns3.bms.com |
bmsi.co.in | NS | 300 |
Target: ns4.bms.com |
bmsi.co.in | NS | 300 |
Target: ns1.bms.com |
bmsi.co.in | NS | 300 |
Target: ns2.bms.com |
bmsi.co.in | SOA | 300 |
MNAME: ns.bms.com RNAME: dnsadmin.bms.com Serial: 2010102434 Refresh: 3600 Retry: 600 Expire: 604800 Minimum TTL: 3600 |
bmsi.co.in | MX | 300 |
Priority: 10 Target: chimera.bms.com |
bmsi.co.in | MX | 300 |
Priority: 20 Target: loki.bms.com |
Full WHOIS Lookup
Registry Domain ID: D3533807-IN
Registrar WHOIS Server:
Registrar URL: https://www.cscglobal.com/global/web/csc/home
Updated Date: 2019-04-01T05:37:15Z
Creation Date: 2009-03-31T21:02:05Z
Registry Expiry Date: 2020-03-31T21:02:05Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited
Domain Status: clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited
Registry Registrant ID:
Registrant Name:
Registrant Organization: Bristol-Myers Squibb Company
Registrant Street:
Registrant Street:
Registrant Street:
Registrant City:
Registrant State/Province: NJ
Registrant Postal Code:
Registrant Country: US
Registrant Phone:
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email: Please contact the Registrar listed above
Registry Admin ID:
Admin Name:
Admin Organization:
Admin Street:
Admin Street:
Admin Street:
Admin City:
Admin State/Province:
Admin Postal Code:
Admin Country:
Admin Phone:
Admin Phone Ext:
Admin Fax:
Admin Fax Ext:
Admin Email: Please contact the Registrar listed above
Registry Tech ID:
Tech Name:
Tech Organization:
Tech Street:
Tech Street:
Tech Street:
Tech City:
Tech State/Province:
Tech Postal Code:
Tech Country:
Tech Phone:
Tech Phone Ext:
Tech Fax:
Tech Fax Ext:
Tech Email: Please contact the Registrar listed above
Name Server: ns2.bms.com
Name Server: ns1.bms.com
Name Server: ns3.bms.com
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2019-12-27T20:08:44Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
Access to .IN WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the .IN registry database. The data in this record is provided by .IN Registry for informational purposes only ,and .IN does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator or a Registrar, or Neustar except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. .IN reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.